U.S. Markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
164.49-0.88 (-0.53%)
At close: 4:00PM EDT
164.50 +0.01 (0.01%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close165.37
Bid164.49 x 800
Ask164.50 x 900
Day's Range164.39 - 165.86
52 Week Range133.65 - 173.65
Avg. Volume7,184,107
Market Cap433.168B
Beta (5Y Monthly)0.72
PE Ratio (TTM)29.06
EPS (TTM)5.66
Earnings DateJul 21, 2021
Forward Dividend & Yield4.24 (2.57%)
Ex-Dividend DateMay 24, 2021
1y Target Est186.65
  • Editor's Pick
    Yahoo Finance Video

    Workers sue over mandatory COVID-19 vaccination

    Yahoo Finance’s Alexis Keenan reports the latest on vaccination mandates and bans on vaccination proof.

  • Reuters

    UPDATE 2-U.S. authorizes another 14 mln doses of Johnson & Johnson's COVID-19 vaccine -sources

    The U.S. Food and Drug Administration on Tuesday authorized around 14 million more doses of Johnson & Johnson's COVID-19 vaccine manufactured at a problem-plagued Baltimore factory, according to two sources familiar with the plans. The FDA confirmed it had authorized a batch of the one-dose vaccine made at Emergent BioSolutions Inc's plant, but did not say how many doses were in the batch. All the J&J doses authorized from the plant to date are expected to be exported to other countries, one of the sources said.

  • Reuters

    UPDATE 1-J&J to send 2 million COVID-19 vaccine doses to S.Africa by end-June -President Ramaphosa

    South African President Cyril Ramaphosa said on Tuesday that Johnson & Johnson would send 2 million COVID-19 vaccine doses to the country by the end of the month, making up for the amount lost due to contamination at an U.S. ingredient supplier. Aspen Pharmacare, J&J's local producer, had to destroy 2 million doses of the vaccine after the contamination at a plant in Baltimore, Maryland, was discovered, the latest blow to South Africa's struggling vaccination campaign. "We have received an indication from Johnson & Johnson that it expects to deliver around 2 million vaccines to South Africa by the end of the month," Ramaphosa said in a televised address.